Tracking the Evolution of Non–Small-Cell Lung Cancer

Mariam Jamal-Hanjani, Gareth A. Wilson, Nicholas McGranahan, Nicolai J. Birkbak, Thomas B.K. Watkins, Selvaraju Veeriah, Seema Shafi, Diana H. Johnson, Richard Mitter, Rachel Rosenthal, Max Salm, Stuart Horswell, Mickael Escudero, Nik Matthews, Andrew Rowan, Tim Chambers, David A. Moore, Samra Turajlic, Hang Xu, Siow-Ming Lee, Martin D. Forster, Tanya Ahmad, Crispin T. Hiley, Christopher Abbosh, Mary Falzon, Elaine Borg, Teresa Marafioti, David Lawrence, Martin Hayward, Shyam Kolvekar, Nikolaos Panagiotopoulos, Sam M. Janes, Ricky Thakrar, Asia Ahmed, Fiona Blackhall, Yvonne Summers, Rajesh Shah, Leena Joseph, Anne M. Quinn, Phil A. Crosbie, Babu Naidu, Gary Middleton, Gerald Langman, Simon Trotter, Marianne Nicolson, Hardy Remmen, Keith Kerr, Mahendran Chetty, Lesley Gomersall, Dean A. Fennell, Apostolos Nakas, Sridhar Rathinam, Girija Anand, Sajid Khan, Peter Russell, Veni Ezhil, Babikir Ismail, Melanie Irvin-Sellers, Vineet Prakash, Jason F. Lester, Malgorzata Kornaszewska, Richard Attanoos, Haydn Adams, Helen Davies, Stefan Dentro, Philippe Taniere, Brendan O’Sullivan, Helen L. Lowe, John A. Hartley, Natasha Iles, Harriet Bell, Yenting Ngai, Jacqui A. Shaw, Javier Herrero, Zoltan Szallasi, Roland F. Schwarz, Aengus Stewart, Sergio A. Quezada, John Le Quesne, Peter Van Loo, Caroline Dive, Allan Hackshaw, Charles Swanton
  • New England Journal of Medicine, June 2017, New England Journal of Medicine (NEJM/MMS)
  • DOI: 10.1056/nejmoa1616288

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1056/nejmoa1616288

The following have contributed to this page: Dr Christophe Dessimoz